Bank of New York Mellon Corp lowered its position in Rhythm Pharmaceuticals, Inc. (NASDAQ:RYTM – Free Report) by 0.5% during the 4th quarter, according to the company in its most recent Form 13F ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback